Danshensu Interventions Mediate Rapid Antidepressant Effects by Activating the Mammalian Target of Rapamycin Signaling and Brain-Derived Neurotrophic Factor Release

키워드

참고문헌 (69)

1. Ménard C, "Pathogenesis of depression : insights from human and rodent studies", Neuroscience, 321, pp.138~162 (2016)
2. Filatova EV, "Major depression : one brain, one disease, one set of intertwined processes", Cells, 10, pp.1283~ (2021)
3. Allahyari E, "Differential item functioning analysis on the Geriatric De pression Scale-15 : An iterative hybrid ordinal logistic regression", Bio medicine(Taipei), 11, pp.23~34 (2021)
4. Keller MB, "Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects", Arch Gen Psychiatry, 49, pp.809~816 (1992)
5. Krystal JH, "Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neu roendocrine responses", Arch Gen Psychiatry, 51, pp.199~214 (1994)
6. Zarate CA Jr, "A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression", Arch Gen Psychiatry, 63, pp.856864~ (2006)
7. Gündüz D, "Role of PI3K", Akt and MEK, Epac-mediated endo thelial barrier stabilisation, pp.Front Physiol, 2019[DOI]
8. Li N, "mTOR-depen dent synapse formation underlies the rapid antidepressant effects of NMDA antagonists", Science, 329, pp.959~964 (2010)
9. Duman RS, "Neurobiology of rapid acting antidepressants : convergent effects on GluA1-synaptic function", Mol Psychiatry, 24, pp.1816~1832 (2019)
10. Wei IH, "Acute ami no acid d-serine administration, similar to ketamine, produces antide pressant-like effects through identical mechanisms", J Agric Food Chem, 65, pp.10792~10803 (2017)
11. Chen KT, "AMPA recep tor-mTOR activation is required for the antidepressant-like effects of sarcosine during the forced swim test in rats : insertion of AMPA recep tor may play a role", Front Behav Neurosci, 9, pp.162~ (2015)
12. Chuang HW, "Echinacoside exhibits an tidepressant-like effects through AMPAR-Akt", ERK-mTOR pathway stimulation and BDNF expression in mice, 2022, pp.17, 9~
13. Chuang HW, "Roles of Akt and ERK in mTOR-dependent antidepressant effects of vanillic acid", ACS Omega, 5, pp.3709~3716 (2020)
14. Huang CC, "Ac tivity dependent mammalian target of rapamycin pathway and brain derived neurotrophic factor release is required for the rapid antidepres sant effects of puerarin", Am J Chin Med, 46, pp.1519~1534 (2018)
15. Yin Y, "Cardioprotective effect of Danshensu against myocardial ischemia", reperfusion injury and inhibits apoptosis of H9c2 cardiomyocytes via Akt and ERK1, Eur J Pharmacol, pp.2013, 699[DOI]
16. Zhou L, "Danshen : an overview of its chemistry, phar macology, pharmacokinetics, and clinical use", J Clin Pharmacol, 45, pp.1345~1359 (2005)
17. Chan K, "Protective effects of Danshensu from the aqueous extract of Salvia miltiorrhiza(Danshen)against homocysteine-induced endothelial dysfunction", Life Sci, 75, pp.3157~3171 (2004)
18. Han JY, "Potential of 3, 4-di hydroxy-phenyl lactic acid for ameliorating ischemia-reperfusion-in duced microvascular disturbance in rat mesentery", Am J Physiol Gas trointest Liver Physiol, 296, pp.G36~G44 (2009)
19. Yang GD, "Down-regu lation of CD40 gene expression and inhibition of apoptosis with Dan shensu in endothelial cells", Basic Clin Pharmacol Toxicol, 104, pp.8792~ (2009)
20. Wang F, "The attenua tion effect of 3, 4-dihydroxy-phenyl lactic acid and salvianolic acid B on venular thrombosis induced in rat mesentery by photochemical reac tion", Clin Hemorheol Microcirc, 42, pp.7~18 (2009)
21. against cerebral ischemia and reperfusion injury in rats, "Phytomedicine", 2015, 283~289
22. Xu H, "Synergistic neuropro tective effects of Danshensu and hydroxysafflor yellow A on cerebral ischemia-reperfusion injury in rats", Oncotarget, 8, pp.115434~115443 (2017)
23. Yu J, "Danshensu protects isolated heart against ischemia reperfusion injury through activation of Akt", ERK1, Nrf2 signaling, pp.Int J Clin Exp Med, 2015[DOI]
24. Chong CM, "Danshensu protects against 6-hydroxydopamine-induced damage of PC12 cells in vitro and dopaminergic neurons in zebrafish", Neurosci Lett, 543, pp.121~125 (2013)
25. Wang T, "Neuroprotective effects of Danshensu on rotenone-induced Parkinson’s disease models in vitro and in vivo", BMC Complement Med Ther, 20, pp.20~ (2020)
26. Wei ZZ, "Enhanced neurogenesis and collaterogenesis by sodium Danshensu treatment af ter focal cerebral ischemia in mice", Cell Transplant, 27, pp.622~636 (2018)
27. Wang T, "Danshensu ameliorates the cognitive decline in streptozotocin-induced diabetic mice by attenuat ing advanced glycation end product-mediated neuroinflammation", J Neuroimmunol, 245, pp.79~86 (2012)
28. in mice, "Life Sci", 2014, 73~78
29. Porsolt RD, "Depression : a new animal model sensitive to antidepressant treatments", Nature, 266, pp.730~732 (1977)
30. Porsolt RD, "Behavioural despair in rats : a new model sensitive to antidepressant treatments", Eur J Pharmacol, 47, pp.379~391 (1978)
31. Du J, "Enhancing AMPA to NMDA throughput as a convergent mech anism for antidepressant action", Drug Discov Today Ther Strateg, 3, pp.519~526 (2006)
32. Du J, "The anti convulsants lamotrigine, riluzole, and valproate differentially regulate AMPA receptor membrane localization : relationship to clinical effects in mood disorders", Neuropsychopharmacology, 32, pp.793~802 (2007)
33. Réus GZ, "Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain", Behav Brain Res, 221, pp.166~171 (2011)
34. Banke TG, "Control of GluR1 AMPA receptor function by cAMP-dependent pro tein kinase", J Neurosci, 20, pp.89~102 (2000)
35. Esteban JA, "PKA phosphorylation of AMPA receptor subunits controls synaptic traffick ing underlying plasticity", Nat Neurosci, 6, pp.136~143 (2003)
36. Smith KE, "cAMP-dependent protein ki nase postsynaptic localization regulated by NMDA receptor activation through translocation of an A-kinase anchoring protein scaffold pro tein", J Neurosci, 26, pp.2391~2402 (2006)
37. Barria A, "Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-KII dur ing long-term potentiation", Science, 276, pp.2042~2045 (1997)
38. Tavalin SJ, "AKAP79 selectively enhances protein kinase C regulation of GluR1 at a Ca2+-calmodulin-dependent protein kinase II", protein ki nase C site, 2008, pp.283, 11445~11452
39. Duman RS, "A neurotrophic model for stress-related mood disorders", Biol Psychiatry, 59, pp.1116~1127 (2006)
40. Lepack AE, "Fast-acting antide pressants rapidly stimulate ERK signaling and BDNF release in prima ry neuronal cultures", Neuropharmacology, 111, pp.242~252 (2016)
41. Yu PF, "The role of P-glycoprotein in transport of danshensu across the blood-brain barri er", Evid Based Complement Alternat Med, 2011, pp.713523~ (2011)
42. Gao Y, "Acute and subchronic toxicity of danshensu in mice and rats", Toxicol Mech Methods, 19, pp.363~368 (2009)
43. Ren R, "Protective effects of Danshensu on liver injury induced by omethoate in rats", Toxicol Mech Methods, 20, pp.510~514 (2010)
44. Tang Y, "Antioxidant and cardioprotective effects of Danshensu(3-(3, 4-dihydroxyphenyl)-2-hy droxy-propanoic acid from Salvia miltiorrhiza)on isoproterenol-induced myocardial hypertrophy in rats", Phytomedicine, 18, pp.1024~1030 (2011)
45. Bakunina N, "Immune mechanisms linked to depression via oxidative stress and neuroprogression", Immunology, 144, pp.365~373 (2015)
46. Galts CPC, "Depression in neurodegenerative diseases : common mecha nisms and current treatment options", Neurosci Biobehav Rev, 102, pp.56~84 (2019)
47. Jernigan CS, "The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder", Prog Neuropsychopharmacol Biol Psychiatry, 35, pp.1774~1779 (2011)
48. Ota KT, "REDD1 is essential for stress-induced synaptic loss and depressive be havior", Nat Med, 20, pp.531~535 (2014)
49. Voleti B, "Scopol amine rapidly increases mammalian target of rapamycin complex 1signaling, synaptogenesis, and antidepressant behavioral responses", Biol Psychiatry, 74, pp.742~749 (2013)
50. Chen J, "Danshen injec tion induces autophagy in podocytes to alleviate nephrotic syndrome via the PI3K", AKT, Phytomedicine, pp.2022, 107[DOI]
51. Fan G, "Danshensu al leviates cardiac ischaemia", reperfusion injury by inhibiting autophagy and apoptosis via activation of mTOR signalling, 2016, pp.20, 1908~1919
52. Gao Q, "Sodium dansh ensu attenuates cerebral ischemia-reperfusion injury by targeting AKT1", Front Pharmacol, 13, pp.946668~ (2022)
53. Hu S, "Sodium Danshensu pro tects against oxygen glucose deprivation", reoxygenation-induced astro cytes injury through regulating NOD-like receptor pyrin domain con taining 3(NLRP3)inflammasome and tuberous sclerosis complex-2(TSC2), Ann Transl Med, pp.2022, 10[DOI]
54. Jia H, "Danshensu enhances cerebral angiogenesis in mice by regulating the PI3K", Akt, VEGF signaling axis, pp.CNS Neurol Disord Drug Targets, 2023[DOI]
55. Tang F, "A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebraf ish and H9c2 cells by inhibiting reactive oxygen species-mediated apop totic and autophagic pathways", Eur J Pharmacol, 820, pp.86~96 (2018)
56. Xie C, "A novel danshensu", tetra methypyrazine derivative attenuates oxidative stress-induced autopha gy injury via the AMPK-mTOR-Ulk1 signaling pathway in cardiomy ocytes, 2021, pp.21, 118~
57. Park SW, "Differential effects of antidepressant drugs on mTOR signalling in rat hippocam pal neurons", Int J Neuropsychopharmacol, 17, pp.1831~1846 (2014)
58. Lu W, "Sub unit composition of synaptic AMPA receptors revealed by a single-cell genetic approach", Neuron, 62, pp.254~268 (2009)
59. Diering GH, "The AMPA receptor code of synaptic plasticity", Neuron, 100, pp.314~329 (2018)
60. Beattie MS, "AMPA-receptor trafficking and injury-induced cell death", Eur J Neurosci, 32, pp.290~297 (2010)
61. Logan SM, "Estrogen-induced signal ing attenuates soluble Aβ peptide-mediated dysfunction of pathways in synaptic plasticity", Brain Res, 1383, pp.1~12 (2011)
62. Schloesser RJ, "Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder", Neuropsychopharmacology, 33, pp.110~133 (2008)
63. Zarate CA Jr, "Cellular plasticity cascades : targets for the development of novel therapeutics for bipolar disorder", Biol Psy chiatry, 59, pp.1006~1020 (2006)
64. Castrén E, "Brain-derived neurotrophic factor signaling in depression and antidepressant action", Biol Psychiatry, 90, pp.128136~ (2021)
65. Chandran A, "Reduced phosphorylation of the mTOR signaling pathway compo nents in the amygdala of rats exposed to chronic stress", Prog Neuropsychopharmacol Biol Psychiatry, 40, pp.240~245 (2013)
66. Duman RS, "Synaptic dysfunction in depression : poten tial therapeutic targets", Science, 338, pp.68~72 (2012)
67. liu S, "Resveratrol exerts antide pressant properties in the chronic unpredictable mild stress model through the regulation of oxidative stress and mTOR pathway in the rat hippocampus and prefrontal cortex", Behav Brain Res, 302, pp.191199~ (2016)
68. Nestler EJ, "Role of the brain’s reward circuitry in depression : transcrip tional mechanisms", Int Rev Neurobiol, 124, pp.151~170 (2015)
69. Shirayama Y, "Altera tions in brain-derived neurotrophic factor(BDNF)and its precursor proBDNF in the brain regions of a learned helplessness rat model and the antidepressant effects of a TrkB agonist and antagonist", Eur Neuropsychopharmacol, 25, pp.2449~2458 (2015)

관련 논문AI추천